Indiana Urologic Association, Inc. (IUA)

Indiana Urologic Association, Inc.

Needs & Objectives

Indiana Urologic Association
2020 Annual Meeting

February 22, 2020
JW Marriott Indianapolis
Indianapolis, Indiana

Educational Needs

Legislative policies at both the national and state level deeply impact the modern practice of medicine. Physicians must remain both informed and proactive regarding Health Policy issues that affect them and their patients. The transition to ICD-10 codes as well as future changes to Medicare billing levels have and will result in unintended consequences for physicians and their businesses. The signing of MACRA into law in 2015 has leveraged physicians and their practices in multiple ways, often complicating and confusing the care of patients. Each year there are new changes to the Quality Payment Program. Urologists must remain informed of these yearly Health Policy changes looming at the state, regional and national levels.

Techniques and technologies in genitourinary reconstructive surgical care have substantially evolved over the past decade. The introduction of American Urological Association Guidelines for the reconstructive urology patient benefit from expert review and presentation. Evolving surgical techniques, new FDA-approved medical therapies, and technological advances in the care of these patients presents a need for both community and academic urologists to familiarize themselves with the impact on their urologic patient. Additionally, the use of Patient-Reported Outcomes measurement and reporting is emerging in the care of the reconstructive urologic patient, which will ultimately have an impact on all urologic care. An understanding of the models being developed for Patient-Reported Outcomes in these patients will help urologists understand the future applications for their practice.

The emergence of multi-drug resistant (MDR) pathogens has been one of the most critical public health problems in the last decades, and the urologic patient is no exception. Hospitalizations for UTI have increased by 76% between 1998 and 2011. In 2011, hospitalizations due to UTI cost $9.7 billion. New testing technologies have been introduced to the market, but their clinical utility is still often uncertain. The American Urologic Association introduced new Best Practice Statements for Urologic Procedures and Antimicrobial Prophylaxis. The practicing urologist must have a clear understanding of the impact of urologic infections as well as the most up to date options for diagnosis, management, and prevention.

To meet workforce needs, urologists have partnered increasingly with Advanced Practice Providers (APPs). As the role of APPs expands within the specialty, there is a growing opportunity to contribute to in-office procedures, which comprise a large part of urologic practice. While necessity is already driving this evolution in care, organized urology has thus far been limited in its endorsement of APPs and many urologic procedures, in part due to a lack of evidence and precedent. This leaves the field with no formal guidance regarding education, training, and guideline development to ensure high quality care. Without formal education, training guidelines, and performance standards, practitioners are left to a paradigm of “on-the-job” training from collaborating physicians, which lends itself to inconsistent training. The panel will present and discuss appropriate training opportunities and methods for the introduction of procedures into the urologic practice of Advanced Practice Providers.

Educational Objectives

At the conclusion of the IUA 2020 Annual Meeting, attendees should be able to:

  1. Identify the Health Policy issues facing Urologists in Indiana, the North Central Section region, and nationally.
  2. Discuss the rules/regulations regarding billing and utilization of Advanced Practice Providers and other urologic team members.
  3. Explain and implement best practices for coding and billing for the outpatient, inpatient and surgical care of the urologic patient.
  4. Discuss current and future aspects of the Quality Payment Program, their impact on urologic practice, and strategies for successful participation in MIPS.
  5. Identify current options and techniques for the surgical care of urethral stricture disease, including appropriate treatment decisions based on location and other condition characteristics.
  6. Describe techniques and treatments for genital reconstruction in cases of obesity, trauma, and other disorders.
  7. Discuss the use of Patient-Reported Outcomes in the care of the surgical patient, particularly the reconstructive urology patient.
  8. Discuss the impact of infection and multi-drug resistant pathogens on the urologic patient population.
  9. Explain and implement best practices for antibiotic stewardship and urologic procedure prophylaxis.
  10. Describe new options for the diagnosis and treatment of urologic infections, and their appropriate applications to their practice.
  11. Discuss current trends in the use of Advanced Practice Providers for the delivery of urologic care.
  12. Discuss the current options for Advanced Practice Providers to receive training and credentialing for the performance of urologic office procedures.
  13. Explain and implement an appropriate training and oversight program for Advanced Practice Providers to incorporate the performance of urologic office procedures into their practice.